Final outcome | Variables | Estimated average | Time standard error | CI (95%) | N Events | N Total | % | p | |
---|---|---|---|---|---|---|---|---|---|
Inferior | Superior | ||||||||
Clinical improvement | Gender | 0.342 | |||||||
Female | 81.97 | 5.52 | 71.15 | 92.80 | 29 | 73 | 39.7 | ||
Male | 70.62 | 12.51 | 46.10 | 95.13 | 8 | 16 | 50.0 | ||
Age (years) | 0.152 | ||||||||
< 60 | 85.56 | 6.55 | 72.72 | 98.40 | 18 | 50 | 36.0 | ||
> = 60 | 71.19 | 7.97 | 55.57 | 86.82 | 19 | 38 | 50.0 | ||
Tumor volume (cc) | 0.102 | ||||||||
< 14 | 72.99 | 6.78 | 59.70 | 86.27 | 25 | 51 | 49.0 | ||
≥ 14 | 89.25 | 7.38 | 74.79 | 103.72 | 12 | 38 | 31.6 | ||
Treatment | 0.972 | ||||||||
SRS | 79.64 | 8.67 | 62.65 | 96.62 | 13 | 32 | 40.6 | ||
SRT | 80.01 | 6.27 | 67.72 | 92.30 | 24 | 57 | 42.1 | ||
Total | 79.95 | 5.08 | 70.00 | 89.90 | 37 | 89 | 41.6 | ||
Radiological improves | Gender | 0.639 | |||||||
Female | 68.75 | 6.12 | 56.76 | 80.75 | 36 | 73 | 49.3 | ||
Male | 76.10 | 12.55 | 51.50 | 100.70 | 7 | 16 | 43.8 | ||
Age (years) | 0.002 | ||||||||
< 60 | 85.02 | 6.93 | 71.45 | 98.59 | 17 | 50 | 34.0 | ||
≥ 60 | 52.54 | 8.05 | 36.77 | 68.31 | 25 | 38 | 65.8 | ||
Tumor volume (cc) | 0.990 | ||||||||
< 14 | 69.93 | 7.22 | 55.79 | 84.08 | 25 | 51 | 49.0 | ||
≥ 14 | 69.96 | 8.57 | 53.17 | 86.74 | 18 | 38 | 47.4 | ||
Treatment | 0.762 | ||||||||
SRS | 68.24 | 9.26 | 50.08 | 86.40 | 16 | 32 | 50.0 | ||
SRT | 71.03 | 6.87 | 57.57 | 84.49 | 27 | 57 | 47.4 | ||
Total | 70.04 | 5.51 | 59.23 | 80.85 | 43 | 89 | 48.3 | ||
Recurrence | 124.49 | 2.19 | 120.20 | 128.79 | 8 | 89 | 8.49 | ||
Log-rank test |